Suppr超能文献

食管腺癌退伍军人中 Barrett 食管筛查和监测的错失机会。

Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.

机构信息

Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine Medical Center, McNair Campus, 7200 Cambridge St., 8th Floor, Suite 8B, Houston, TX, 77030, USA.

Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.

出版信息

Dig Dis Sci. 2019 Feb;64(2):367-372. doi: 10.1007/s10620-018-5336-5. Epub 2018 Oct 28.

Abstract

BACKGROUND

Barrett's esophagus (BE) is the premalignant lesion of esophageal adenocarcinoma (EAC) and is the target of early detection and prevention efforts for EAC.

AIMS

We sought to evaluate what proportion and temporal trends of EAC patients had missed opportunities for screening and surveillance of BE.

METHODS

Our study included 182 patients with EAC at the Michael E. DeBakey VA Medical Center in Houston, Texas, between 02/2005 and 09/2017. We conducted a retrospective audit of patients' medical records for any previous upper endoscopies (EGDs) for screening or surveillance of BE prior to their EAC diagnosis.

RESULTS

The mean age of the cohort was 67.3 years (SD = 9.5); 99.5% of patients were male, and 85.2% were white. Only 45 patients (24.7%) had EGD at any time prior to the cancer diagnosing EGD, of whom 29 (15.9% of all EAC cases) had an established BE diagnosis. In the 137 patients with no prior EGD, most (63.5%) had GERD or were obese or ever smokers. There were no changes in patterns over time. For the 29 patients with prior established BE, 22 (75.8%) were diagnosed with EAC as a result of surveillance EGD. Patients with prior established BE were more likely to be diagnosed at 0 or I stage (p < 0.001) and managed with endoscopic or surgical modalities (p < 0.001) than patients without prior BE.

CONCLUSIONS

Despite having established risk factors for BE, the majority of EAC patients had no prior EGD to screen for BE. BE screening may represent the largest missed opportunity to reduce EAC mortality.

摘要

背景

巴雷特食管(BE)是食管腺癌(EAC)的癌前病变,是 EAC 早期检测和预防工作的目标。

目的

我们旨在评估有多少比例和时间趋势的 EAC 患者错过了 BE 的筛查和监测机会。

方法

我们的研究包括 2005 年 2 月至 2017 年 9 月在德克萨斯州休斯顿的迈克尔 E. 德贝基退伍军人事务医疗中心的 182 名 EAC 患者。我们对患者的病历进行了回顾性审计,以了解在 EAC 诊断之前是否有任何先前的上消化道内镜(EGD)用于筛查或监测 BE。

结果

队列的平均年龄为 67.3 岁(SD=9.5);99.5%的患者为男性,85.2%为白人。只有 45 名患者(24.7%)在癌症诊断 EGD 之前的任何时间进行过 EGD,其中 29 名(所有 EAC 病例的 15.9%)有明确的 BE 诊断。在 137 名没有先前 EGD 的患者中,大多数(63.5%)有 GERD 或肥胖或曾经吸烟。随着时间的推移,模式没有变化。对于 29 名先前有明确 BE 的患者,22 名(75.8%)因监测 EGD 而被诊断为 EAC。与没有先前 BE 的患者相比,先前有明确 BE 的患者更有可能被诊断为 0 期或 I 期(p<0.001),并接受内镜或手术治疗(p<0.001)。

结论

尽管存在 BE 的既定危险因素,但大多数 EAC 患者没有先前的 EGD 来筛查 BE。BE 筛查可能是降低 EAC 死亡率的最大错失机会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验